Therapeutic Plasma Exchange (TPE) for Alzheimer’s

A Simple, Evidence-Based Look at the Research

Alzheimer’s disease (AD) is a tough condition that gets worse over time. It involves harmful protein buildups in the brain, ongoing inflammation, and loss of brain cells. Most current treatments only help with symptoms a little. But one approach called Therapeutic Plasma Exchange (TPE) — sometimes with albumin replacement — is showing promise in studies for slowing things down.

First off, What is TPE?

Therapeutic Plasma Exchange, or TPE, is a sophisticated blood purification procedure that gently removes the plasma portion of your blood — the liquid that carries antibodies, inflammatory proteins, cytokines, toxins, and metabolic waste — and replaces it with a sterile albumin.

Your own red blood cells are returned to your body, creating a powerful “reset” for your bloodstream. Sessions typically last 2–4 hours in a calm, outpatient setting and are performed under the supervision of experienced medical professionals.

Think of TPE as a deep internal cleanse — far more targeted than traditional detox protocols — that helps restore balance and supports your body’s innate ability to heal and thrive.

How Does TPE Work for Alzheimer’s?

TPE Clears Harmful Proteins:

Alzheimer’s has lots of amyloid-beta (Aβ) proteins that clump up and damage the brain. TPE pulls these (and other junk) out of the blood. This may create a “pull” that draws more harmful proteins out of the brain. Fresh albumin helps bind and remove them.

TPE Lowers Inflammation:

TPE removes inflammatory chemicals, cytokines, and other troublemakers from the blood. Less inflammation in the body and brain can protect brain cells. Albumin also has anti-inflammatory and antioxidant perks.

It’s a broader approach than drugs that target just one thing (like amyloid only).

The Big Study: AMBAR Trial

The strongest evidence comes from the AMBAR study — a large, well-designed trial with hundreds of patients who had mild to moderate Alzheimer’s.

• Patients had regular TPE sessions: intensive weekly ones at first, then monthly maintenance.
• After 14 months, the TPE group did better than the placebo (fake treatment) group:
  • 52% less decline in everyday activities (like managing meds or meals).
  • 66% less decline in thinking/memory tests (trend, close to significant).
  • Overall function: 71% less decline on a key rating scale; doctors saw basically no worsening vs. clear decline in placebo.
• People with moderate Alzheimer’s saw the biggest benefits: about 61% less decline in key tests.

Thousands of procedures were done across the study.

TPE for Alzheimers: Real-World Results Back It Up

A 2025 study in Argentina looked at 32 patients getting TPE in normal clinic settings (compared to similar past patients who didn’t get it).

• 45% slower decline on a standard memory test (MMSE).
• Big improvements in memory recall (up to 88% less worsening).
• Very safe: Over 500 procedures, most went smoothly, no serious problems.

This matches the big trial and shows it can work outside perfect study conditions.

Important Caveats about TPE for Alzheimers:

• It slows decline — it doesn’t cure or reverse Alzheimer’s.
• Stronger results in moderate stages than very mild in some data.
• It takes multiple sessions over months, which means time and access to specialists.
• More large studies are still needed to confirm long-term effects and best protocols.

It’s not yet a standard treatment everywhere, but it’s an exciting option being explored in specialized clinics.

TPE for Alzheimers Treatment: The Bottom Line

TPE with albumin looks like a promising way to slow Alzheimer’s by cleaning the blood of harmful proteins and calming inflammation. Major studies show 50-70% less decline in thinking and daily function for many patients — better than many approved drugs on these measures.

If you or a loved one are dealing with Alzheimer’s, talk to a specialist who is experienced with this procedure, like us here at Beyond Functional Medicine in Newport Beach, CA. It’s one piece of a bigger care plan that includes lifestyle, meds, and monitoring.

Key Sources:

• Boada et al. (2020) — AMBAR main results. Alzheimer’s & Dementia.
• Taragano et al. (2025) — Real-world study. Journal of Alzheimer’s Disease.
• Supporting reviews on mechanisms (e.g., Rohrer 2023 and others).

Research about Alzheimers treatment with TPE is ongoing, and we are always keeping up with the latest news and study results.

Learn more about Therapeutic Plasma Exchange in Newport Beach, CA HERE